Pseudomyxoma peritonei (PMP) is a rare abdominal cancer originating in the appendix, causing extensive tumour growth in the peritoneal cavity. Although rare, PMP still dramatically affects the lives of almost 4,000 new persons in Europe every year, posing a huge financial and logistical challenge for health-care providers. If complete surgical removal cannot be accomplished at expert centres, prognosis is very poor, and no other effective treatments are currently available.
Because it is a rare disease, research into the pathogenesis, classification, molecular composition and treatment of PMP has been fragmented and challenging. The EuroPMP Action aims to sculpt a new, collaborative landscape within PMP research through the creation of a strong and capable network of experts from many fields, including surgeons, pathologists, oncologists, radiologists, molecular biologists, bioinformaticians and allied health care professionals. The Action will work towards a cure for PMP through the facilitation of collaborative research projects, the sharing and dissemination of knowledge, and the improvement of standards of care for the thousands of patients afflicted with PMP.
More information about the EuroPMP COST Action can be found here.
To join EuroPMP, click here.